Joe Jones
Ask VT AI
View News Summary
- UBS launches new $2 billion share buyback despite Swiss capital rule threat, reaffirming commitment to capital returns.
- Moderna's mRNA-based flu vaccine outperforms standard flu shot in global Phase 3 trial, paving the way for COVID-19 combination vaccines.
- Deadly ambush on Idaho firefighters leaves community in shock, as authorities investigate the motive behind the premeditated attack.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- UBS launches new $2 billion share buyback despite Swiss capital rule threat, reaffirming commitment to capital returns.
- Moderna's mRNA-based flu vaccine outperforms standard flu shot in global Phase 3 trial, paving the way for COVID-19 combination vaccines.
- Deadly ambush on Idaho firefighters leaves community in shock, as authorities investigate the motive behind the premeditated attack.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Joe Jones
News from Joe Jones